Skip to main content

Table 6 Factors associated with anticoagulant therapy in patients with prior stroke

From: Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study

 BOR (95% CI)p value
Univariate analysis
 Gender, female0.3191.376 (0.473~4.004)0.559
 Self-paying0.3601.434 (0.401~5.130)0.580
 Age, (per 1 year increase)0.0551.057 (1.005~1.112)0.031
  ≥ 75 years old1.1073.025 (1.001~9.142)0.050
 Education− 0.2790.757 (0.220~2.608)0.659
 AF type, Permanent−0.2350.791 (0.132~4.726)0.797
 Duration, ≥5 years−0.2760.759 (0.259~2.224)0.615
 Severity of symptom0.8822.415 (0.499~11.682)0.273
 HAS-BLED, score ≥ 3−0.7060.494 (0.167~1.455)0.200
 CHA2DS2-VASc, (per 1 score increase)0.2281.257 (0.851~1.856)0.251
 Vascular disease− 05530.5752 (0.177~1.870)0.358
 Congestive heart failure0.2051.227 (0.120~12.597)0.863
 Diabetes mellitus0.5351.708 (0.518~5.631)0.379
 Hypertension−0.3430.710 (0.238~2.116)0.538
Multivariate analysis
 Age, (per 1 year increase)0.0731.075 (1.016~1.139)0.013
  ≥ 75 years old0.4591.583 (0.239~10.483)0.634
 Self-paying0.3421.407 (0.359~5.515)0.624
 AF type, Permanent−0.5680.567 (0.079~4.066)0.572
 Duration, ≥5 years−0.3020.739 (0.220~2.481)0.625
 HAS-BLED, score ≥ 3−1.0610.346 (0.102~1.175)0.089
  1. Abbreviations: AF atrial fibrillation, CHA2DS2-VASc Congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke, transient ischemic attack, or thromboembolism, vascular disease, age 65–74 years, sex category (female), CI Confidence interval, HAS-BLED Hypertension, abnormal renal and/or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly (age > 65 years), drugs and/or alcohol concomitantly, OR Odds ratio